XOMA Royalty Corp (XOMA)
30.69
+0.49
(+1.62%)
USD |
NASDAQ |
Nov 08, 16:00
30.69
0.00 (0.00%)
After-Hours: 20:00
XOMA Royalty Revenue (Annual): 4.758M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 4.758M |
December 31, 2022 | 6.027M |
December 31, 2021 | 38.16M |
December 31, 2020 | 29.38M |
December 31, 2019 | 18.37M |
December 31, 2018 | 5.299M |
December 31, 2017 | 52.69M |
December 31, 2016 | 5.564M |
December 31, 2015 | 55.45M |
December 31, 2014 | 18.87M |
December 31, 2013 | 35.45M |
December 31, 2012 | 33.78M |
December 31, 2011 | 58.20M |
December 31, 2010 | 33.64M |
December 31, 2009 | 98.43M |
December 31, 2008 | 67.99M |
December 31, 2007 | 84.25M |
December 31, 2006 | 29.50M |
December 31, 2005 | 18.67M |
December 31, 2004 | 3.665M |
Date | Value |
---|---|
December 31, 2003 | 24.41M |
December 31, 2002 | 29.95M |
December 31, 2001 | 17.28M |
December 31, 2000 | 6.659M |
December 31, 1999 | 2.40M |
December 31, 1998 | 6.30M |
December 31, 1997 | 18.40M |
December 31, 1996 | 3.60M |
December 31, 1995 | 1.20M |
December 31, 1994 | 1.70M |
December 31, 1993 | 0.60M |
December 31, 1992 | 5.10M |
December 31, 1991 | 17.10M |
December 31, 1990 | 20.50M |
December 31, 1989 | 10.40M |
December 31, 1988 | 5.00M |
December 31, 1987 | 7.70M |
December 31, 1986 | 0.10M |
December 31, 1985 | 7.30M |
December 31, 1984 | 5.90M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
4.758M
Minimum
2023
38.16M
Maximum
2021
19.34M
Average
18.37M
Median
2019
Revenue (Annual) Benchmarks
Twist Bioscience Corp | 245.11M |
Dynavax Technologies Corp | 232.28M |
NovaBay Pharmaceuticals Inc | 14.73M |
Palatin Technologies Inc | 4.490M |
iBio Inc | 0.225M |